Press Releases

Antibodies show highly selective binding to pathogenic forms of alpha-synuclein implicated in multiple system atrophy TORONTO and CAMBRIDGE, MA, Oct. 8, 2019 /PRNewswire/ - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therap

BIRMINGHAM, Ala. and DALLAS, Oct. 8, 2019 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) is proud to announce its Dallas-based home health and hospice segment has been named to Modern Healthcare's Best Places to Work in Healthcare for 2019. This is the eighth year the organization has been named to the

EAST HANOVER, N.J., Oct. 8, 2019 /PRNewswire/ -- Novartis today announced that the U.S. Food and Drug Administration (FDA) approved BEOVU® (brolucizumab-dbll) injection, also known as RTH258, for the treatment of wet age-related macular degeneration (AMD)1. BEOVU is the first FDA-approved anti-VEGF to offer both greater fluid resolution versus a

ST. LOUIS, Oct. 8, 2019 /PRNewswire/ -- Express Scripts announced today its Express Scripts Medicare® prescription drug plan (PDP) offerings for 2020, with three high-value options for coverage and savings – Saver, Value and Choice – including a $0 copay on all Tier 1 drugs v

Dissolve Strips ™ Now Available to Aurora's Canadian Medical PatientsNYSE | TSX: ACB OTC: CTTH EDMONTON and HAMILTON, ON, Oct. 8, 2019 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, and CTT Pharmaceu

NEWTOWN, Pa., Oct. 8, 2019 /PRNewswire/ -- CenTrak, Inc., the global leader in Real-Time Location Systems (RTLS), announces the recent addition of three RTLS related patents, US Patent Nos. 8,907,754, 9,622,030, and 10,126,407, to its ongoing dispute with Sonitor Technologies, Inc. In addition, CenTrak voluntarily removed from the dispute

SOUTH SAN FRANCISCO, Calif., Oct. 8, 2019 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that it has achieved a milestone under its collaboration and license agreement with the healthcare division of Merck KGaA, Darmstadt, Germany and is entitled to receive a milestone payment.  The milestone was achieved upon t

NEW YORK and LONDON, Oct. 8, 2019 /PRNewswire/ -- Health Sciences Acquisitions Corporation ("HSAC," NASDAQ: HSAC), a special purpose acquisition company sponsored by RTW Investments, and Immunovant Sciences Ltd. ("Immunovant"), a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune disease

INDIANAPOLIS, Oct. 8, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it will present new data for Taltz® (ixekizumab), Olumiant® (baricitinib) and mirikizumab at the 28th annual European Academy of Dermatology and Venereology (EADV) Congress taking place Oct. 9-13 in

DENVER, Oct. 8, 2019 /PRNewswire/ -- The SAFE (Stem cell experts Advocating For Ethical treatment) study group, a panel that consisted of 27 academics and Regenerative Medicine physician experts from a dozen universities and from many different specialties, have just produced the world's first consensus re